Miguel Ángel Gamero-García

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

External Validation of the ISAN, A2DS2, and AIS-APS Scores for Predicting Stroke-Associated Pneumonia

Elena Zapata‐Arriaza, Francisco Moniche, Blanca Pardo‐Galiana et al. · Journal of Stroke and Cerebrovascular Diseases · 2017 · 50 citations

Life Sciences, Clinical Sciences, Infectious Diseases +15

Intra-Arterial Bone Marrow Mononuclear Cells (BM-MNCS) Transplantation in Acute Ischemic Stroke (IBiS Trial): Protocol of a Phase II, Randomized, Dose-Finding, Controlled Multicenter Trial

Francisco Moniche, Irene Escudero‐Martínez, Elena Zapata‐Arriaza et al. · International Journal of Stroke · 2015 · 45 citations

Medicine, Neurology, Cell Therapy +13

Differential cognitive impairment for diverse forms of multiple sclerosis

Javier J. González-Rosa, Manuel Vázquez-Marrufo, Encarnación Vaquero et al. · BMC Neuroscience · 2006 · 43 citations · Full text

Life Sciences, Neurology, Neuroscience +16

Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial

Francisco Moniche, Juan Antonio Cabezas-Rodriguez, Roberto Valverde et al. · The Lancet Neurology · 2023 · 30 citations

Medicine, Neurology, Cell Therapy +11